Health
OHDSI awarded $10 MM FDA contract to monitor safety/effectiveness of vaccines, biologics – EurekAlert
A team of observational health data researchers, coordinated by Columbia University, will support an FDA program to conduct safety and effectiveness surveillance…
NEW YORK, NY (Dec. 1, 2020)–Researchers within the Observational Health Data Services and Informatics (OHDSI) community were recently awarded a $10 million contract from the U.S. Food and Drug Administration (FDA) to provide support to the Biologics Effectiveness and Safety (BEST) program, which was launched by the FDA Center for Biologics Evaluation and Research (CBER) in 2017.
The lead research team, primarily comprised of OHDSI personnel from Columbia University, UCLA, and Northeastern University,…
-
Business24 hours agoWhat it means for shareholders
-
Noosa News24 hours agoCalls for greater education as growers in WA’s south-west brace for polyphagous shot-hole borer
-
Noosa News14 hours agoNRL legend Trevor Gillmeister charged with assaulting police officer at Brisbane pub
-
General22 hours agoKim Kardashian not deterred by bar failure